CONMED Corp. buy Needham & Company LLC
Start price
26.10.23
/
50%
€91.00
Target price
26.10.24
€112.99
Performance (%)
-36.26%
End price
27.10.24
€58.00
Summary
This prediction ended on 27.10.24 with a price of €58.00. The BUY prediction by Needham___Company_LL for CONMED Corp. performed very badly with a performance of -36.26%. Needham___Company_LL has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. Dividends of €0.73 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 0.581% | 0.581% | -49.855% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Needham___Company_LL for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $140.00 to $119.00. They now have a "buy" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten

